AO "SZTSDM", Saint Petersburg

Accounting reports

Previously








Share:
Name
AKTSIONERNOE OBSCHESTVO "SEVERO-ZAPADNYY TSENTR DOKAZATEL'NOY MEDITSINY"
INN
7813316148
KPP
781001001
OGRN
1057810089523
OKPO
76179013
FFSM
16797-J
Address
196246, G.sankt-peterburg, sh Pulkovskoe, d. D. 28, of. POMESCH. 21-N, KABINET 22
Phone
+7 (812) 600-47-12  Contact details

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
AO "SZTSDM" according to EGRUL

OKVED codeTypeName of activity type
86.90.9Core activityOther independent activities in health care
47.73Additional activity Retailing drugs in specialized stores (pharmacies)
47.74Additional activity Retailing products used for medical purposes, orthopedic goods in specialized stores
All types of activities
72.19Additional activity Research and experimental development on natural sciences and engineering Other
82.30Additional activity Activities of the organization of conferences and exhibitions
85.42Additional activityTertiary education 8530 *
85.42.9Additional activity Activities for additional professional education, not included in other categories
86.10Additional activityHospitals
86.21Additional activity General practice
86.90Additional activity Activities in the field of medicine other
Registration date
22.02.2005
Registering department
Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N15 po Sankt-Peterburgu

AO "SZTSDM" (Saint Petersburg; INN 7813316148) was registered on 22 Feb 2005. The company's authorized capital as of July 1, 2012 was 3600000 rub.

Type of ownership of AO "SZTSDM" - Closed joint-stock companies.

Form of ownership of AO "SZTSDM" - Combines private and foreign property.

Principal activities of AO "SZTSDM": other independent activities in health care (86.90.9), retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74).

Economic indicators

2023

Net profit (RAS) of AO SZTSDM grew over 2023 by 1.02% to 889.00 thousand RUB from 880.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period by 25.51% to 741.51 million RUB from 995.38 million RUB in 2022; cost of goods sold decreased by 22.20% to 623.19 million RUB from 801.05 million RUB; sales loss made up 12.12 million RUB compared to sales profit of 43.76 million RUB.

2022

Net profit (RAS) of AO SZTSDM grew over 2022 by 43.56% to 880.00 thousand RUB from 613.00 thousand RUB over 2021, the company informed.

Revenue decreased in the accounting period by 15.64% to 995.38 million RUB from 1.18 billion RUB in 2021; cost of goods sold decreased by 19.64% to 801.05 million RUB from 996.85 million RUB; sales profit went up 2.49 times to 43.76 million RUB from 17.58 million RUB.

2021

Net profit (RAS) of AO SZTSDM dropped in 2021 4.53 times to 613.00 thousand RUB from 2.77 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period by 17.63% to 1.18 billion RUB from 1.00 billion RUB over 2020; cost of goods sold grew by 16.88% to 996.85 million RUB from 852.90 million RUB; sales profit fell by 24.64% to 17.58 million RUB from 23.32 million RUB.

2020

Net profit (RAS) of AO SZTSDM dropped in 2020 by 25.23% to 2.77 million RUB from 3.71 million RUB over the same period in 2019, the company informed.

Revenue increased in the accounting period by 13.72% to 1.00 billion RUB from 882.07 million RUB over 2019; cost of goods sold grew by 20.93% to 852.90 million RUB from 705.31 million RUB; sales profit went up by 33.05% to 23.32 million RUB from 17.53 million RUB.

2019

Net profit (RAS) of AO SZTSDM dropped in 2019 by 42.24% to 3.71 million RUB from 6.42 million RUB over the same period in 2018, the company informed.

Revenue increased in the accounting period by 10.32% to 882.07 million RUB from 799.56 million RUB over 2018; cost of goods sold grew by 15.76% to 705.31 million RUB from 609.29 million RUB; sales profit fell by 47.56% to 17.53 million RUB from 33.43 million RUB.

2018

Net profit (RAS) of AO SZTSDM grew over 2018 by 43.08% to 6.42 million RUB from 4.49 million RUB over 2017, the company informed.

Revenue increased in the accounting period by 10.65% to 799.56 million RUB from 722.62 million RUB over 2017; cost of goods sold grew by 12.79% to 609.29 million RUB from 540.18 million RUB; sales profit went up by 13.72% to 33.43 million RUB from 29.40 million RUB.

2017

Net profit (RAS) of AO SZTSDM grew over 2017 3.32 times to 4.49 million RUB from 1.35 million RUB over 2016, the company informed.

Revenue increased in the accounting period by 10.44% to 722.62 million RUB from 654.31 million RUB over 2016; cost of goods sold grew by 11.46% to 540.18 million RUB from 484.62 million RUB; sales profit went up by 24.84% to 29.40 million RUB from 23.55 million RUB.

2016

Net profit (RAS) of AO SZTSDM grew over 2016 1.77 times to 1.35 million RUB from 766.00 thousand RUB over 2015, the company informed.

Revenue increased in the accounting period by 17.49% to 654.31 million RUB from 556.90 million RUB over 2015; cost of goods sold grew by 16.40% to 484.62 million RUB from 416.35 million RUB; sales profit went up 1.99 times to 23.55 million RUB from 11.82 million RUB.

2014

Net profit (RAS) of SEVERO-ZAPADNYY TSENTR DOKAZATEL'NOY MEDITSINY, ZAO grew over 2014 by 21.46% to 22.18 million RUB from 18.26 million RUB over 2013, the company informed.

Revenue increased in the accounting period by 27.40% to 477.34 million RUB from 374.67 million RUB over 2013; cost of goods sold grew by 27.36% to 291.30 million RUB from 228.73 million RUB; sales profit went up by 20.90% to 40.33 million RUB from 33.36 million RUB.

2013

Net profit (RAS) of SEVERO-ZAPADNYY TSENTR DOKAZATELNOY MEDITSINY, ZAO grew over 2013 18.06 times to 18.26 million RUB from 1.01 million RUB over 2012, the company informed.

Revenue increased in the accounting period by 27.35% to 374.67 million RUB from 294.20 million RUB over 2012; cost of goods sold grew by 25.91% to 228.73 million RUB from 181.66 million RUB; sales profit went up 1.71 times to 33.36 million RUB from 19.48 million RUB.

2012

Net profit (RAS) of Severo-Zapadnyjj Centr dokazatelnojj mediciny, ZAO made up 1.01 million RUB over 2012 compared to net loss of 8.35 million RUB over 2011, the company informed.

Cost of goods sold grew by 11.06% to 181.66 million RUB from 163.56 million RUB; sales profit went up 7.71 times to 19.48 million RUB from 2.53 million RUB.




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 335 814
Reports
17 430 600
Rrocessed requests
Extract from EGRUL:
Today, 10:55 AM
Accounting reports:
Today, 10:59 AM
The site can contain materials of 16+ category
+7(495) 729−17−96,    info@k-agent.ru
Рейтинг@Mail.ru © "Info-RL", 2006—2025
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru